- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Epidermal growth factor receptor mutations
Total 59035 results
-
Eli Lilly and CompanyUniversity of Colorado, Denver; PPD; Parexel; ICON Clinical Research; Laboratory... and other collaboratorsActive, not recruitingNon Small Cell Lung CancerUnited States, Belgium, Brazil, Russian Federation, Serbia, Spain, United Kingdom, Germany, Australia, Hungary, Italy, Romania, Austria, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Philippines, Canada, Korea,... and more
-
Regeneron PharmaceuticalsActive, not recruitingAdvanced Non-small Cell Lung CancerUnited States
-
Bristol-Myers SquibbCompletedBreast CancerChina, Russian Federation, United States, Italy, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Colombia, Czechia, Denmark, Finland, France, Germany, Hong Kong, Ireland, Korea, Republic of, Mexico, Netherlands, Poland, Portuga... and more
-
Merus N.V.CompletedBreast Cancer MetastaticUnited States, France, Belgium, Spain, United Kingdom, Netherlands, Portugal
-
Hoffmann-La RocheCompleted
-
University of Kansas Medical CenterPfizerTerminatedHER2-positive Breast Cancer | Breast Cancer MetastaticUnited States
-
Merck Sharp & Dohme LLCActive, not recruitingBreast NeoplasmsKorea, Republic of, Germany, United States, United Kingdom, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Phili... and more
-
AstraZenecaActive, not recruitingMetastatic Triple Negative Breast CancerUnited States, Belgium, Italy, Spain, United Kingdom, Canada, Czechia, Poland, France, Korea, Republic of, Germany, Taiwan, Portugal, Netherlands, Ireland
-
Hadassah Medical OrganizationCompletedRash Due to Epidermal Growth Factor Receptor Inhibitors
-
Janssen Research & Development, LLCYuhan CorporationCompletedCarcinoma, Non-Small-Cell LungUnited Kingdom, United States, Spain
-
National Cancer Institute (NCI)Active, not recruitingMalignant Solid NeoplasmUnited States
-
Providence Health & ServicesMerck Sharp & Dohme LLCActive, not recruitingTriple Negative Breast CancerUnited States
-
Hoffmann-La RocheCompleted
-
AstraZenecaDaiichi SankyoCompletedBreast CancerDenmark, Finland, Italy, Norway, Spain, Sweden, Poland, United States, Canada, Germany, Japan, Netherlands, Portugal, Switzerland, Australia, United Kingdom, Belgium, Ireland
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Canada, Thailand, Vietnam, France, Korea, Republic of, Brazil, India, Japan, Peru, Philippines, Russian Federation, China, Taiwan, United Kingdom, Czechia, Chile, Australia, Argentina, Slovakia, South Africa
-
Guangdong Association of Clinical TrialsActive, not recruitingCarcinoma, Non-Small-Cell LungChina
-
Eli Lilly and CompanyAstraZenecaCompletedNon-small Cell Lung CancerSpain, United States, Korea, Republic of, Taiwan, France
-
Memorial Sloan Kettering Cancer CenterXcovery Holding Company, LLCActive, not recruiting
-
Erasca, Inc.Active, not recruitingGlioblastoma MultiformeUnited States
-
Boehringer IngelheimCompleted
-
PfizerCompletedBreast Cancer MetastaticArgentina, United Kingdom
-
Accutar Biotechnology IncTerminated
-
Zeno Pharmaceuticals, Inc.CompletedCarcinoma, Non-Small-Cell LungUnited States, Bosnia and Herzegovina
-
Incyte CorporationAstraZenecaActive, not recruitingLung CancerUnited States, Korea, Republic of, Spain, Taiwan
-
Arvinas Estrogen Receptor, Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain
-
Merck Sharp & Dohme LLCCompletedNon-small Cell Lung CancerChina, Taiwan, Japan, Korea, Republic of, United States, Australia, Brazil, Canada, France, Germany, Hong Kong, Israel, Italy, Mexico, Spain, Sweden, United Kingdom
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer InstituteTerminatedBreast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Node-negative Breast CancerUnited States
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Active, not recruitingHR-positive, HER2-negative Breast NeoplasmsChina
-
European Organisation for Research and Treatment...Active, not recruitingMalignant Neoplasm of Stomach | Malignant Neoplasm of Cardio-esophageal Junction of Stomach | Epidermal Growth Factor Receptor (EGFR) Protein OverexpressionSpain, Korea, Republic of, Singapore, Switzerland, Germany, United Kingdom, Italy, France, Estonia, Belgium, Netherlands, Norway, Portugal
-
PfizerActive, not recruitingHR+ HER2- Metastatic Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer, Triple Negative Breast Cancer, Male Breast CancerUnited States, Japan, Canada, Russian Federation, Bulgaria, Ukraine
-
Eisai Co., Ltd.Active, not recruiting
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
PfizerCompletedBreast Cancer | Breast Neoplasms | Breast Tumors | Breast Carcinoma | Cancer of BreastIndia
-
Merck Sharp & Dohme LLCActive, not recruitingBreast CancerJapan, Poland, United States, Australia, Belgium, Brazil, Canada, China, Colombia, Costa Rica, France, Germany, Hungary, Ireland, Israel, Korea, Republic of, New Zealand, Portugal, Puerto Rico, Russian Federation, Spain, Taiwan, Ukr... and more
-
PfizerCompleted
-
Daiichi Sankyo Co., Ltd.Daiichi Sankyo, Inc.CompletedMetastatic Breast CancerUnited States, Japan
-
University of NebraskaNational Cancer Institute (NCI)TerminatedStage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | HER2-negative Breast CancerUnited States
-
Novartis PharmaceuticalsCompletedCarcinoma, Non-Small-Cell LungBelgium, Germany, Italy, France, Netherlands, Spain, Korea, Republic of, India, Brazil, Portugal
-
North Eastern German Society of Gynaecological...Center for Clinical Trials Philipps University MarburgActive, not recruitingEstrogen Receptor Positive Tumor | Primary Invasive Breast Cancer | Human Epidermal Growth Factor Receptor 2 Negative TumorGermany, Switzerland
-
Incyte CorporationCompletedNon-Small Cell Lung Cancer (NSCLC)Spain, United States, Italy, Germany, France
-
Eisai Co., Ltd.Active, not recruiting
-
PfizerWithdrawnBreast Cancer | Ovarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Solid Tumors | Liposarcoma | Endometrial
-
Boehringer IngelheimCompleted
-
PfizerCompleted
-
BayerCompletedCancers With HER2 ExpressionUnited States, United Kingdom
-
The Netherlands Cancer InstituteBoehringer Ingelheim; Merck Serono International SACompletedCarcinoma, Non-Small-Cell LungNetherlands
-
M.D. Anderson Cancer CenterNovartisCompletedBreast Cancer | Neoplasm MetastasisUnited States
-
Sun Yat-sen UniversityFirst Affiliated Hospital, Sun Yat-Sen University; Sun Yat-Sen Memorial Hospital...Active, not recruitingBreast Cancer | Neoadjuvant ChemotherapyChina
-
Oana Danciu, MDPfizer; Big Ten Cancer Research ConsortiumActive, not recruitingMetastatic Breast Cancer | Hormone Receptor Positive Malignant Neoplasm of Breast | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Estrogen Receptor Positive Breast Cancer | Progesterone Receptor Positive TumorUnited States
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedNon-Small-Cell Lung CarcinomaUnited States, China, Taiwan, Spain, Korea, Republic of, France, Canada, Hong Kong, Japan, Singapore